Verapamil and Capivasertib: Interaction Details

Brand names
Capivasertib
Truqap
Verapamil
CalanCalan SRCovera HS +3 more
Dr. Brian Staiger, PharmD, BCPS

Medically reviewed by ⁠

Also reviewed by the HelloPharmacist Editorial Team Updated AI-assisted Details about this page
Share

Share this interaction

Verapamil

Brand names
  • Calan
  • Calan SR
  • Covera HS
  • Verelan
  • Verelan PM
  • Isoptin

What Happens When You Take Verapamil With Capivasertib

What can happen when they are taken together (rated Major)

Increased capivasertib exposure and an increased risk of capivasertib-related adverse reactions

Interaction Deep Dive

A note from Dr. Brian Staiger If you’re a patient, this deep dive may be too technical, or bore you (or both). Read the plain-language explanation →

Moderate raise capivasertib exposure, which may raise the risk of adverse reactions to capivasertib, a CYP3A .1 If the two are given together, the capivasertib dosage should be lowered to 320 mg orally twice daily for 4 days, followed by 3 days off, and patients should be monitored for adverse reactions. Once the moderate CYP3A is stopped, the capivasertib dosage taken before the inhibitor was started should be resumed, after an interval of 3 to 5 half-lives of the inhibitor.

The Verapamil and Capivasertib Interaction, Explained

Verapamil can raise the amount of capivasertib in your body. Verapamil slows down , a liver and gut enzyme that helps clear capivasertib. With less clearing, more capivasertib stays in your system, which can make capivasertib side effects more likely. These can include diarrhea, high blood sugar, rash, and nausea.

This is a known, manageable interaction. Your care team may adjust and individualize your capivasertib dose and may monitor you more closely. Keep taking both medicines as prescribed, and tell your pharmacist or doctor about any new symptoms.

Mechanism: Verapamil is a moderate . It inhibits CYP3A-mediated of capivasertib (a CYP3A ), increasing capivasertib exposure and the risk of adverse reactions (e.g., , diarrhea, rash). Capivasertib is not a , so raises exposure. Onset is unspecified. Evidence: probable. Severity: major.

  • Labeling: reduce capivasertib to 320 mg orally twice daily for 4 days on, 3 days off.
  • Monitor for adverse reactions, including glucose and /skin toxicity.
  • After stopping verapamil, resume the prior capivasertib dose after 3 to 5 inhibitor half-lives.

See the 1 reference behind this explanation ↓

From the HelloPharmacist Pharmacy Team

AI-assisted: written with AI from this pair’s record in our interaction database, and reviewed by the HelloPharmacist pharmacy team. Written .

How we build these pages · How we use AI · Our editorial policy

Why Verapamil and Capivasertib Interact

The likely mechanism

of -mediated of capivasertib

In short: Verapamil slows CYP3A, an enzyme that breaks down capivasertib, so capivasertib can build up in the body.
How Drug Interactions Work See this kind of interaction drawn out, step by step, in “When One Drug Raises Another’s Level”, one chapter of our one-minute explainer. See how it works 

How to Manage the Verapamil and Capivasertib Interaction

Your care team can manage this interaction by tailoring your capivasertib dose and watching you more closely.

  • When capivasertib is taken with a moderate such as verapamil, the documented approach is a reduced capivasertib schedule (320 mg twice daily for 4 days, then 3 days off), set by your prescriber.
  • Your team will monitor you for side effects.
  • If verapamil is stopped, your team will decide when to return to your previous capivasertib dose, typically after 3 to 5 half-lives of verapamil have passed.

Keep taking both medicines as prescribed, and do not change doses on your own. Report new or worsening side effects to your pharmacist or prescriber.

Management is individual — confirm any change with your pharmacist or prescriber.

Questions for Your Pharmacist

  • Does my dose of Verapamil or Capivasertib need adjusting while I take them together?
  • What symptoms should prompt me to call you or my prescriber right away?
  • Does the timing of my doses matter for this combination?
  • Is there another option that avoids this interaction?

Literature Reports

1 report from the published literature. Each one is headed by the title of the published study it comes from.

What these reports are. Short summaries of published evidence on this combination: clinical studies, case reports and, at times, the FDA prescribing information for one of the drugs. They support this interaction, but it does not rest on them alone. It can also rest on prescribing information not summarized here, or on what is expected from how these two drugs, and others in their drug classes, are known to work.

  1. Report 1 · Study title

    Prescribing information: TRUQAP oral tablets, capivasertib oral tablets

    administration of capivasertib with erythromycin and verapamil (moderate ) is predicted to raise capivasertib 1.3-fold and 1.5-fold.1

Verapamil and Capivasertib: Common Questions

How serious is the Verapamil and Capivasertib interaction?

It is rated major. Potentially serious — often needs a change or close monitoring.

How is the Verapamil and Capivasertib interaction managed?

Your care team can manage this interaction by tailoring your capivasertib dose and watching you more closely. When capivasertib is taken with a moderate such as verapamil, the documented approach is a reduced capivasertib schedule (320 mg twice daily for 4 days, then 3 days off), set by your prescriber. Your team will monitor you for side effects. If verapamil is stopped, your team… Management is individual — always follow your own care team's guidance.

Does taking Verapamil and Capivasertib at different times of day help?

No. Taking them at different times of day does not prevent this one. Verapamil slows , an enzyme that breaks down capivasertib, so capivasertib can build up in the body. That change lasts while verapamil is being taken and can continue for a while after the last dose.

Your pharmacist or prescriber can tell you how they will manage it.

How quickly could this interaction happen?

The documented onset is "unspecified". The timing of this interaction is not well characterized.

How strong is the evidence for this interaction?

The evidence is graded "probable". Good supporting evidence, though not definitively proven.

Ask About the Verapamil and Capivasertib Interaction

Ask in your own words about taking Verapamil and Capivasertib together. The answer comes from this page’s interaction record and both drugs’ own information.

This box answers questions about this one combination only. For anything else about either drug, open its drug information page or ask a pharmacist.

Try:

AI answers from this page’s record and both drugs’ information, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.

References (1)

  1. Product Information: TRUQAP(TM) oral tablets, capivasertib oral tablets. AstraZeneca Pharmaceuticals LP (per FDA), Wilmington, DE, 2023. DailyMed
Was this write-up helpful?

Other Serious Interactions of Verapamil and Capivasertib

Also serious with Capivasertib

Also serious with Verapamil

These Medications Also Interact With Supplements

Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:

With Capivasertib

With Verapamil

Check everything you take with our drug–supplement interaction checker.

Still Have Questions About This Combination?

Every question gets a real answer from a licensed pharmacist — free, as soon as they can.

About This Library

Built in-house, documented one interaction at a time. Our interaction database is not a complete list of every known interaction: a combination that isn't listed here hasn't been documented by us yet, which never means it's safe. Checking everything you take at once? Ask your pharmacist to review your full medication list. How we build and review it →

What Each Rating Means

Severity Levels

  • Contraindicated These should generally not be used together.
  • Major Potentially serious — often needs a change or close monitoring. This interaction.
  • Moderate Can be significant — usually manageable with monitoring.
  • Minor Usually limited clinical impact.

Evidence Grades

  • EstablishedWell documented — supported by controlled studies or strong clinical data.
  • ProbableGood supporting evidence, though not definitively proven. This interaction.
  • SuspectedSome evidence suggests this interaction, but it is not well established.
  • PossibleLimited or conflicting evidence; the interaction may occur.
  • TheoreticalExpected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study.

How Soon It Shows

  • RapidEffects can appear quickly, often within about 24 hours of combining the drugs.
  • DelayedEffects tend to build up gradually over days to weeks.
  • UnspecifiedThe timing of this interaction is not well characterized. This interaction.

Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.

Back to the answer
This information is for education, not a substitute for professional medical advice. Do not start, stop, or change any medication without talking to your pharmacist or prescriber.